Sounds good but it's 3 million out of QBL/MCL coughers for this research over 3 years, we need to be bringing in some serious revenue if we are potentially going to fund this & also the first million for Canntab should it be realized here in Australia & Asia.
Looking forward to seeing some revenue figures or announcements that are going to raise revenue in the short to medium term, I agree its critical to invest in the future but the books need to reflect our capacity to do so, don't want to extend ourselves beyond means.
I got a good feeling sales are going to be strong though! I have faith in QBL & Andrew to make the right calls.
QBL Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held
